$MED News

MED Q3 deep dive: new Trilogy brand and coach productivity drive evolving metabolic health strategy

5 insightful analyst questions from Medifast’s Q3 earnings call

Medifast Is Running The Same Playbook, And I Have The Same Concerns

Why Medifast (MED) stock is trading up today

Medifast (MED) Q3 Results Deepen Losses As Coach Decline Persists

Medifast Q3 Loss Narrower Than Expected as Coach Productivity Rises

Medifast (MED) Q3 2026 Earnings Call Transcript

What Medifast (MED) Said on Its Q3 Earnings Call

Medifast, Inc. Reports Third Quarter 2026 Revenue of $72.0 million

Medifast (NYSE:MED) Q3 2026 Earnings: Adjusted Loss Narrows as Revenue Meets Estimates

Medifast, Inc. 2026 Q3 - Results - Earnings Call Presentation

Medifast (NYSE:MED) exceeds Q3 2026 expectations, full-year outlook slightly exceeds expectations

Medifast (MED) Reports Q3 Loss, Tops Revenue Estimates

Medifast: Q3 Earnings Snapshot

Medifast Announces Third Quarter 2026 Financial Results

Medifast, Inc. (MED) Q3 2026 Earnings Call Transcript

Medifast Q3 2026 Earnings Call Transcript

Medifast Lowers FY2026 GAAP EPS Guidance from $(1.75)-$(0.25) to $(2.05)-$(1.80) vs $(0.94) Est

Medifast Sees FY2026 Adj EPS $(0.70)-$(0.45) vs $(0.94) Est; Raises FY2026 Sales Guidance from $270.000M-$300.000M to $280.000M-$300.000M vs $287.700M Est

Medifast Q3 Adj. EPS $(0.19) Beats $(0.35) Estimate, Sales $72.048M Beat $71.300M Estimate